GSK Price to Sales Ratio 2010-2023 | GSK
Historical PS ratio values for GSK (GSK) over the last 10 years. The current P/S ratio for GSK as of June 02, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| GSK P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-06-02 |
34.11 |
|
2.20 |
| 2023-03-31 |
35.23 |
$15.53 |
2.27 |
| 2022-12-31 |
34.46 |
$17.93 |
1.92 |
| 2022-09-30 |
28.57 |
$21.79 |
1.31 |
| 2022-06-30 |
52.26 |
$23.46 |
2.23 |
| 2022-03-31 |
51.89 |
$24.74 |
2.10 |
| 2021-12-31 |
51.77 |
$23.32 |
2.22 |
| 2021-09-30 |
44.30 |
$22.61 |
1.96 |
| 2021-06-30 |
45.61 |
$21.97 |
2.08 |
| 2021-03-31 |
40.33 |
$21.08 |
1.91 |
| 2020-12-31 |
40.84 |
$21.76 |
1.88 |
| 2020-09-30 |
41.21 |
$21.79 |
1.89 |
| 2020-06-30 |
44.13 |
$22.03 |
2.00 |
| 2020-03-31 |
40.52 |
$22.35 |
1.81 |
| 2019-12-31 |
49.59 |
$21.55 |
2.30 |
| 2019-09-30 |
44.54 |
$19.17 |
2.32 |
| 2019-06-30 |
41.29 |
$18.75 |
2.20 |
| 2019-03-31 |
42.61 |
$18.74 |
2.27 |
| 2018-12-31 |
38.39 |
$20.80 |
1.85 |
| 2018-09-30 |
39.88 |
$22.57 |
1.77 |
| 2018-06-30 |
39.54 |
$22.41 |
1.76 |
| 2018-03-31 |
37.85 |
$22.19 |
1.71 |
| 2017-12-31 |
33.76 |
$19.76 |
1.71 |
| 2017-09-30 |
38.10 |
$19.44 |
1.96 |
| 2017-06-30 |
39.95 |
$19.29 |
2.07 |
| 2017-03-31 |
38.62 |
$19.32 |
2.00 |
| 2016-12-31 |
34.79 |
$19.23 |
1.81 |
| 2016-09-30 |
38.51 |
$19.41 |
1.98 |
| 2016-06-30 |
38.30 |
$19.22 |
1.99 |
| 2016-03-31 |
35.41 |
$19.03 |
1.86 |
| 2015-12-31 |
34.17 |
$18.88 |
1.81 |
| 2015-09-30 |
32.13 |
$18.75 |
1.71 |
| 2015-06-30 |
34.36 |
$18.57 |
1.85 |
| 2015-03-31 |
37.57 |
$18.87 |
1.99 |
| 2014-12-31 |
34.29 |
$19.29 |
1.78 |
| 2014-09-30 |
36.39 |
$20.33 |
1.79 |
| 2014-06-30 |
41.77 |
$20.99 |
1.99 |
| 2014-03-31 |
41.25 |
$21.22 |
1.94 |
| 2013-12-31 |
40.67 |
$21.47 |
1.89 |
| 2013-09-30 |
37.77 |
$21.16 |
1.79 |
| 2013-06-30 |
37.22 |
$21.10 |
1.76 |
| 2013-03-31 |
34.57 |
$21.06 |
1.64 |
| 2012-12-31 |
31.55 |
$21.37 |
1.48 |
| 2012-09-30 |
33.11 |
$21.27 |
1.56 |
| 2012-06-30 |
32.27 |
$21.55 |
1.50 |
| 2012-03-31 |
31.42 |
$21.83 |
1.44 |
| 2011-12-31 |
31.35 |
$21.56 |
1.45 |
| 2011-09-30 |
28.01 |
$21.77 |
1.29 |
| 2011-06-30 |
28.76 |
$21.14 |
1.36 |
| 2011-03-31 |
25.44 |
$20.59 |
1.24 |
| 2010-12-31 |
25.57 |
$20.92 |
1.22 |
| 2010-09-30 |
25.43 |
$21.56 |
1.18 |
| 2010-06-30 |
21.61 |
$21.92 |
0.99 |
| 2010-03-31 |
24.17 |
$22.17 |
1.09 |
| 2009-12-31 |
26.11 |
$21.34 |
1.22 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$69.205B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
